Gary S. Gillheeney, Sr. is the President and CEO of Organogenesis Holdings Inc. since December 2018. He has built a reputation for leading the company in the biotechnology sector, focusing on regenerative medicine. Born in 1962, Gary holds a Bachelor's...
Gary S. Gillheeney, Sr. is the President and CEO of Organogenesis Holdings Inc. since December 2018. He has built a reputation for leading the company in the biotechnology sector, focusing on regenerative medicine. Born in 1962, Gary holds a Bachelor's degree in Business Administration. Over the years, he has successfully grown the company’s revenue and guided key strategic decisions. In 2022, his total compensation reached approximately $6 million, reflecting both a solid base salary and performance bonuses which drive his focus on results. Gary's value as a leader is highlighted by his long-standing commitment to employee benefits, including health and insurance coverages that keep the workforce motivated. His strong ties to shareholder interests are seen in the stock options that align executives with the company’s success, enhancing long-term growth. Gary has always been a straightforward leader who emphasizes results over promises, making him an influential figure in the industry.